The Peculiar Trialogue between Pediatric Obesity, Systemic Inflammatory Status, and Immunity

Lorena Elena Meliț1, Cristina Oana Mărginean1, Cristian Dan Mărginean1

  • 1Department of Pediatrics I, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Gheorghe Marinescu Street No 38, 540136 Târgu Mureș, Romania.

Biology
|July 2, 2021
PubMed

Insights

Pediatric obesity is a complex multisystem disorder, not just an energy imbalance. It triggers chronic inflammation and serious health complications in children, impacting their quality of life.

Area of Science:

  • Pediatric Endocrinology
  • Immunology
  • Metabolic Disorders

Background:

  • Pediatric obesity is a growing global health crisis, characterized by an energetic imbalance leading to chronic inflammation.
  • Obesity is increasingly recognized as a complex multisystem disorder with severe short- and long-term health consequences for children.
  • Adipose tissue, far from being inert, functions as an endocrine and immune organ, releasing adipokines that modulate inflammatory responses.

Purpose of the Study:

  • To highlight the systemic inflammatory nature of pediatric obesity.
  • To emphasize the role of adipose tissue as an immune organ in the context of childhood obesity.
  • To explore the potential of complete cellular blood count parameters as inflammatory predictors in pediatric obesity.

Main Methods:

  • Review of current literature on pediatric obesity and its associated inflammatory mechanisms.
  • Analysis of the immunological functions of adipose tissue, including adipokine signaling.
  • Evaluation of the utility of complete cellular blood count parameters in identifying inflammation in pediatric patients with overweight or obesity.

Main Results:

  • Obesity in children results in adipocyte hypertrophy/hyperplasia and chronic inflammation.
  • Adipose tissue contains diverse immune cells (macrophages, neutrophils, lymphocytes, etc.) that contribute to inflammation.
  • Adipokines amplify immune responses, and complete cellular blood count parameters (leukocytes, lymphocytes, neutrophils) can predict obesity-related inflammation in children.

Conclusions:

  • Pediatric obesity is a chronic inflammatory condition with multisystem implications.
  • Adipose tissue plays a critical role in the immune dysregulation associated with childhood obesity.
  • Complete cellular blood count parameters offer a potential tool for monitoring obesity-induced inflammation in pediatric populations.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
469
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
820
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
102
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
486
What is the Immune System?01:38

What is the Immune System?

Overview
119.8K